Patents by Inventor Xiangyong GU

Xiangyong GU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11377426
    Abstract: The present invention relates to a scalable process for the making of elagolix, its salts and the process of intermediate compounds.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: July 5, 2022
    Assignee: SUZHOU PENGXU PHARMATECH CO., LTD.
    Inventors: Pixu Li, Peng Wang, Xiangyong Gu, Hailong Yang, Zhong Wang, Qianghua Jiang, Yuanhua Liu, Hui Xia
  • Patent number: 11161851
    Abstract: The present invention relates to a method for preparing the compound of formula IV, compound of formula XI, and acalabrutinib, a new generation of bruton tyrosine kinase (BTK) inhibitor.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: November 2, 2021
    Assignee: Suzhou PengXu Pharmatech Co. Ltd.
    Inventors: Peng Wang, Pixu Li, Xiangyong Gu, Yadong Ge, Zhong Wang, Feng Gao, Qiangqiang Du
  • Publication number: 20210214318
    Abstract: The present invention relates to a scalable process for the making of elagolix, its salts and the process of intermediate compounds.
    Type: Application
    Filed: December 3, 2018
    Publication date: July 15, 2021
    Applicant: SUZHOU PENGXU PHARMATECH CO., LTD.
    Inventors: Pixu LI, Peng WANG, Xiangyong GU, Hailong YANG, Zhong WANG, Qianghua JIANG, Yuanhua LIU, Hui XIA
  • Publication number: 20200354368
    Abstract: The present invention relates to a method for preparing the compound of formula IV, compound of formula XI, and acalabrutinib, a new generation of bruton tyrosine kinase (BTK) inhibitor.
    Type: Application
    Filed: November 5, 2018
    Publication date: November 12, 2020
    Applicant: SUZHOU PENGXU PHARMATECH CO., LTD.
    Inventors: Peng WANG, Pixu LI, Xiangyong GU, Yadong GE, Zhong WANG, Feng GAO, Qiangqiang DU